China Medicine Corporation (CHME)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 16.95 Million | 4.2 Million | -2.31 Million | -2.21 Million | -32.5 Thousand | 2.54 Million |
| Net Income | 1.4 Million | 9.12 Million | 6.87 Million | 4.78 Million | -32.5 Thousand | 2.93 Million |
| Depreciation & Amortization | 1.01 Million | 420.76 Thousand | 784.11 Thousand | 162.05 Thousand | - | 122.01 Thousand |
| Deferred income taxes | 21.24 Thousand | 45.84 Thousand | - | - | - | -107.09 Thousand |
| Stock-based compensation | 131.12 Thousand | 88.46 Thousand | - | - | - | - |
| Change in working capital | 7.11 Million | -5.35 Million | -10.07 Million | -7.95 Million | - | -505.83 Thousand |
| Other non-cash items | 7.27 Million | -118.26 Thousand | 103.23 Thousand | 787.44 Thousand | - | 97.52 Thousand |
| Investing Cash Flow | -13.53 Million | -7.86 Million | -389.58 Thousand | -826.49 Thousand | - | -8722.00 |
| Investments in PPE | -3.67 Million | -2.66 Million | -389.58 Thousand | -826.49 Thousand | - | -8722.00 |
| Acquisitions | -8 Million | - | - | - | - | - |
| Investment purchases | - | -5.19 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -1.86 Million | - | - | - | - | - |
| Financing Cash Flow | -5.74 Million | 362.5 Thousand | 7.82 Million | 3.48 Million | 34.5 Thousand | -2.44 Million |
| Debt repayment | -10.63 Million | - | - | - | - | -121 Thousand |
| Dividends payments | - | - | - | - | - | -2.32 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 7.82 Million | 3.78 Million | 2102.00 | - |
| Other Financing Activities | 4.88 Million | 362.5 Thousand | - | -294.09 Thousand | 32.39 Thousand | -121 Thousand |
| Accounts receivables | -2.27 Million | -4.78 Million | - | - | - | - |
| Accounts payables | 608.58 Thousand | -20.68 Thousand | - | - | - | - |
| Inventory | 3.36 Million | -491.87 Thousand | -1.84 Million | -498.62 Thousand | - | -596 Thousand |
| Other working capital | 5.41 Million | -54.13 Thousand | -8.23 Million | -7.45 Million | - | 90.17 Thousand |
| Cash at beginning of period | 2.79 Million | 5.76 Million | 371.48 Thousand | 91.96 Thousand | - | 148.85 Thousand |
| Cash at end of period | 471.76 Thousand | 2.79 Million | 5.76 Million | 371.48 Thousand | 2000.00 | 243.52 Thousand |
| Capital Expenditure | -3.67 Million | -2.66 Million | -389.58 Thousand | -826.49 Thousand | - | -8722.00 |
| Effect of forex changes on cash | 5954.00 | 315.72 Thousand | 266.31 Thousand | -164.69 Thousand | - | - |
| Net cash flow / Change in cash | -2.32 Million | -2.97 Million | 5.39 Million | 279.51 Thousand | 2000.00 | 94.67 Thousand |
| Free Cash Flow | 13.28 Million | 1.54 Million | -2.69 Million | -3.04 Million | -32.5 Thousand | 2.53 Million |
| Breakdown | 2010 Q3 | 2010 Q2 | 2010 Q1 | 2009 Q4 | 2009 FY | 2009 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 2.14 Million | 4.02 Million | 1.72 Million | -2.16 Million | 1.4 Million | 3.13 Million |
| Depreciation & Amortization | 423.84 Thousand | 466.92 Thousand | 462.22 Thousand | 348.5 Thousand | 1.01 Million | 229.71 Thousand |
| Deferred income taxes | - | - | - | -5861.00 | 21.24 Thousand | -714.00 |
| Stock-based compensation | 140.09 Thousand | 89.99 Thousand | 2914.00 | 29.79 Thousand | 131.12 Thousand | 53.28 Thousand |
| Change in working capital | -2.48 Million | -6.83 Million | 350.88 Thousand | 10.06 Million | 7.11 Million | -1.55 Million |
| Other non-cash items | -563.37 Thousand | -1.25 Million | -1.1 Million | 5.16 Million | 7.27 Million | 141.68 Thousand |
| Investing Cash Flow | -3.7 Million | -38.91 Thousand | -77.03 Thousand | -6.47 Million | -13.53 Million | -4.52 Million |
| Investments in PPE | -4.43 Million | -108.03 Thousand | -64.01 Thousand | 30.66 Thousand | -3.67 Million | -3.08 Million |
| Acquisitions | - | - | - | - | -8 Million | - |
| Investment purchases | - | - | -13.01 Thousand | - | - | -1.44 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 725.89 Thousand | 69.12 Thousand | - | -6.5 Million | -1.86 Million | 3.00 |
| Financing Cash Flow | 2.81 Million | 1.41 Million | 9.25 Million | -8.73 Million | -5.74 Million | 2.95 Million |
| Debt repayment | -3.02 Million | - | - | - | -10.63 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 12 Million | - | - | - |
| Other Financing Activities | 5.83 Million | 1.41 Million | -2.74 Million | - | 4.88 Million | - |
| Accounts receivables | 7.86 Million | -3.24 Million | 788.75 Thousand | -6.55 Million | -2.27 Million | 433.03 Thousand |
| Accounts payables | -1.66 Million | -141.15 Thousand | 1.33 Million | 365.73 Thousand | 608.58 Thousand | 103.09 Thousand |
| Inventory | -1.91 Million | -163.91 Thousand | -972.29 Thousand | 6.58 Million | 3.36 Million | 68.81 Thousand |
| Other working capital | -6.77 Million | -3.28 Million | -795.62 Thousand | 9.66 Million | 5.41 Million | -2.16 Million |
| Cash at beginning of period | 9 Million | 11.08 Million | 471.76 Thousand | 2.24 Million | 2.79 Million | 1.81 Million |
| Cash at end of period | 7.85 Million | 9 Million | 11.08 Million | 471.76 Thousand | 471.76 Thousand | 2.24 Million |
| Capital Expenditure | -4.43 Million | -108.03 Thousand | -64.01 Thousand | 30.66 Thousand | -3.67 Million | -3.08 Million |
| Effect of forex changes on cash | 94.03 Thousand | 43.83 Thousand | 6123.00 | 7239.00 | 5954.00 | 1544.00 |
| Net cash flow / Change in cash | -1.15 Million | -2.08 Million | 10.61 Million | -1.77 Million | -2.32 Million | 428.38 Thousand |
| Free Cash Flow | -4.78 Million | -3.61 Million | 1.36 Million | 13.46 Million | 13.28 Million | -1.09 Million |
NIPOF
CBVTF
MDG1
WELSPUNLIV
PLT
EMDF